A researcher works in a lab run by Moderna Inc, who said November 16, 2020 that its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial, in an undated still image from video.
Moderna | via Reuters
Dr. Lou Edje enrolled in the Moderna vaccine trial at her health system in Cincinnati, Ohio, after three of her relatives died from the coronavirus this year. That made her want to do more to inspire confidence in her community to get vaccinated.
“I felt that I might be able to have an impact that has some credibility, for the patients that I take care of every day who look just like me,” said Edje, who is Black and the associate…